WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

R RESPIRATORY SYSTEM

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.


R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE

This group comprises plain and combined antihistamine preparations for systemic use. Antihistamines used in motion sickness are classified in this group. Other preparations used in motion sickness, see A04 - Antiemetics and antinauseants.
See also N07C - Antivertigo preparations.
Combined preparations (incl. combinations with hydroxyzine) are classified at separate 5th levels using the corresponding 50-series.
Combinations of antihistamines are classified at a separate 4th level, R06AK.
Antihistamines are also included in combined preparations classified in other groups:
Combinations with analgesics - N02
Combinations with xanthines - R03DA
Combinations with leukotriene receptor antagonists - R03DC.
Combinations with expectorants - R05C
Combinations with nasal decongestants for systemic use - R01B
Combinations with cough suppressants - R05D
Allergen extracts, see V01.
The group is subdivided according to chemical structure.

For some of the substances, different dosage forms are given different DDDs, due to differences in bioavailability.


R06AE Piperazine derivatives

Cinnarizine and flunarizine are classified in N07C - Antivertigo preparations.


    ATC code  Name  DDD  U Adm.R Note
    R06AE05 meclozine 50 mg 
    50 mg 

List of abbreviations

Last updated: 2024-01-26